Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold protein

PLoS ONE

Volumn 3, Issue 2, 2008, Pages

  Blanco, Sandra ^a   Sanz García, Marta ^a   Santos, Claudio R ^a   Lazo, Pedro A ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 7; OLIGOMER; PHOSPHOTRANSFERASE; PROTEIN SERINE THREONINE KINASE; RECEPTOR; REGULATOR PROTEIN; SCAFFOLD PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; VACCINIA RELATED KINASE 2; MAPK8IP1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VRK2 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN BINDING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; DOWN-REGULATION; HUMANS; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 45749097781     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001660     Document Type: Article

References (69)

1. Hacfliger JA, Tawadros T, Mcylan L, Gurun SL, Rochrich ME, et al. (2003) The scaffold protein IBI/JIP-1 is a critical mediator of cytokine-induced apoptosis in pancreatic beta cells. J Cell Sci 116: 1463-1469.
2. Helbecque N, Abderrahamani A, Meylan L, Riederer B, Mooser V, et al. (2003) Islet-brain1/C-Jun N-terminal kinase interacting protein-1 (IBI/ JIP-1) promoter variant is associated with Alzheimer's disease. Mol Psychiatry 8: 413-422, 363.
3. Scheinfeld MH, Matsuda S, D'Adamio L (2003) JNK-interacting protein-1 promotes transcription of A beta protein precursor but not A beta precursor-like proteins, mechanistically different than Fe65. Proc, Natl Acad Sci U S A 100: 1729-1734.
4. Waeber G, Delplanque J, Bonny C, Mooser V, Steinmann M, et al. (2000) The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat Genet 24: 291-295.
5. Kolch W, Calder M, Gilbert D (2005) When kinases meet mathematics: the systems biology of MAPK signalling. FEBS Lett 579: 1891-1895.
6. Kolch W (2005) Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol.
7. Hazzalin CA, Mahadevan LC (2002) MAPK-regulated transcription: a continuously variable gene switch? Nat Rev Mol Cell Biol 3: 30-40.
8. Yang S-H, Sharrocks AD, Whitmarsh AJ (2003) Transcriptional regulation by the MAP kinase signaling cascades. Gene 320: 3-21.
9. Whitmarsh AJ, Davis RJ (1999) Signal transduction by MAP kinases: regulation by phosphorylation-dependent switches. Sci STKE 1999: PE1.
10. Ichijo H (1999) From receptors to stress-activated MAP kinases. Oncogene 18: 6087-6093.
11. Dunn C, Wiltshire C, MacLaren A, Gillespie DA (2002) Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor. Cell Signal 14: 585-593.
12. Cuevas BD, Abell AN, Johnson GL (2007) Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene 26: 3159-3171.
13. Liu J, Lin A (2005) Role of JNK activation in apoptosis: a double-edged sword. Cell Res 15: 36-42.
14. Tournier C, Whitmarsh AJ, Cavanagh J, Barret T, Davis RJ (1997) Mitogen-activated protein kinase 7 is an activator of the jun NH2-terminal kinase. Proc Natl Acad Sci USA 94: 7337-7342.
15. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252.
16. Karin M, Gallagher E (2005) From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 57: 283-295.
17. Dhanasekaran DN, Kashef K, Lee CM, Xu H, Reddy EP (2007) Scaffold proteins of MAP-kinase modules, Oncogene 26: 3185-3202.
18. Yamano S, Tokino T, Yasuda M, Kaneuchi M, Takahashi M, et al. (1999) Induction of transformation and p53-dependent apoptosis by adenovirus type 5 E4orf6/7 cDNA. J Virol 73: 10095-10103.
19. Bonny C, Oberson A, Steinmann M, Schorderet DF, Nicod P, et al. (2000) IB1 reduces cytokine-induced apoptosis of insulin-secreting cells. J Biol Chem 275: 16466-16472.
20. Whitmarsh AJ, Cavanagh Tournier C, Yasuda J, Davis RJ (1998) A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281: 1671-1674.
21. Whitmarsh AJ, Kuan CY, Kennedy NJ, Kelkar N, Haydar TF, et al. (2001) Requirement of the JIP1 scaffold protein for stress-induced JNK activation. Genes Dev 15: 2421-2432.
22. Song JJ, Lee YJ 2005) Dissociation of Akt1 from its negative regulator JIP1 is mediated through the ASK1-MEK-JNK signal transduction pathway during metabolic oxidative stress: a negative feedback loop. J Cell Biol 170: 61-72.
23. Scheinfeld MH, Roncarati R, Vito P, Lopez PA, Abdallah M, et al. (2002) Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1) binds the cytoplasmic domain of the Alzheimer's beta-amyloid precursor protein (APP). J Biol Chem 277: 3767-3775.
24. Dong Z, Zhou L, Del Villar K, Ghanevati M, Tashjian V, et al. (2005) JIP1 regulates neuronal apoptosis in response to stress. Brain Res Mol Brain Res 134: 282-293.
25. Liew FY, Xu D, Brint EK, O'Neill LA (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5: 446-458.
26. Symons A, Beinke S, Ley SC (2006) MAP kinase kinase kinases and innate immunity. Trends Immunol 27: 40-48.
27. Nakahira M, Tanaka T, Robson BE, Mizgerd JP, Grusby MJ (2007) Regulation of Signal Transducer and Activator of Transcription Signaling by the Tyrosine Phosphatase PTP-BL. Immunity 26: 163-176.
28. Round JL, Humphries LA, Tomassian T, Mittelstadt P, Zhang M, et al. (2007) Scaffold protein Dlgh1 coordinates alternative p38 kinase activation, directing T cell receptor signals toward NFAT but not NF-kappaB transcription factors. Nat Immunol 8: 154-161.
29. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002) The protein kinase complement of the human genome. Science 298: 1912-1934.
30. Nezu J, Oku A, Jones MH, Shimane M (1997) Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus BIR kinase. Genomics 45: 327-331.
31. Vega FM, Sevilla A, Lazo PA (2004) p53 Stabilization and Accumulation Induced by Human Vaccinia-Related Kinase 1. Mol Cell Biol 24: 10366-10380.
32. Lazo PA, Vega FM, Sevilla A (2005) Vaccinia-related kinase-1. Afes Nature Molecule Page doi:10.1038/: mp.a003025.003001.
33. Lopez-Borges S, Lazo PA (2000) The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein. Oncogene 19: 3656-3664.
34. Valbuena A, Vega FM, Blanco S, Lazo PA (2006) p53 Downregulates Its Activating Vaccinia-Related Kinase 1, Forming a New Autoregulatory Loop. Mol Cell Biol 26: 4782-4793.
35. Sevilla A, Santos CR, Vega FM, Lazo PA (2004) Human Vaccinia-related Kinase 1 (VRK1) Activates the ATF2 Transcriptional Activity by Novel Phosphorylation on Thr-73 and Ser-62 and Cooperates with JNK. J Biol Chem 279: 2745-27465.
36. Sevilla A, Santos CR, Barcia R, Vega FM, Lazo PA (2004) c-Jun phosphorylation by the Human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK). Oncogene 23: 8950-8958.
37. Nichols RJ, Wiebe MS, Traktman P (2006). The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in tke nucleus. Mol Biol Cell 17: 2451-2464.
38. Gorjanacz M, Klerkx EP, Galy V, Santarella R, Lopez-Iglesias C, et al. (2007) Caenorhabditis elegans BAF-1 and its kinase VRK-1 participate directly in postmitotic nuclear envelope assembly. Embo J 26: 132-143.
39. Nichols RJ, Traktman P (2004) Characterization of three paralogous members of the Mammalian vaccinia related kinase family. J Biol Chem 279: 7934-7946.
40. Blanco S, Klimcakova L, Vega FM, Lazo PA (2006) The subcellular localization or vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines. Febs J 273: 2487-2504.
41. Kang TH, Kim KT (2006) Negative regulation of ERK activity by VRK3-mediated activation of VHR phosphatase. Nat Cell Biol 8: 863-869.
42. Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, et al. (2005) TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 19: 2668-2681.
43. Hammaker DR, Boyle DL, Chabaud-Riou M, Firestein GS (2004) Regulation of c-jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis. J Immunol 172: 1612-1618.
44. Jensen LE, Whitehead AS (2003) Pellino2 activates the mitogen activated protein kinase pathway. FEBS Lett 545: 199-202.
45. Cheung PC, Campbell DG, Nebreda AR, Cohen P (2003) Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha. Embo J 22: 5793-5805.
46. Windheim M, Lang C, Peggie M, Plater LA, Cohen P (2007) Molecular mechanisms involved in the regulation or cytokine production by muramyl dipeptide. Biochem J 404: 179-190.
47. Holtmann H, Enninga J, Kalble S, Thiefes A, Dorrie A, et al. (2001) The MAPK kinase kinase TAK1 plays a central role in coupling the interleukin-1 receptor to both transcriptional and RNA-targeted mechanisms of gene regulation. J Biol Chem 276: 3508-3516.
48. Takaesu G, Ninomiya-Tsuji J, Kishida S, Li X, Stark GR, et al. (2001) Interleukin-1 (IL-1) Receptor-Associated Kinase Leads to Activation of TAK1 by Inducing TAB2 Translocation in the IL-1 Signaling Pathway. Mol Cell Biol 21: 2475-2484.
49. Jiang Z, Ninomiya-Tsuji J, Qian Y, Matsumoto K, Li X (2002) Interleukin-1 (IL-1) Receptor-Associated Kinase-Dependent IL-1-Induced Signaling Complexes Phosphorylate TAK1 and TAB2 at the Plasma Membrane and Activate TAK1 in the Cytosol. Mol Cell Biol 22: 7158-7167.
50. Yao J, Kim TW, Qin J, Jiang Z, Qian Y, et al. (2007) Interleukin-1 (IL-1)-induced TAK1-dependent Versus MEKK3-dependent NFkappaB activation pathways bifurcate at IL-1 receptor-associated kinase modification. J Biol Chem 282: 6075-6089.
51. Blanco S, Santos C, Lazo PA (2007) Vaccinia-Related Kinase 2 Modulates the Stress Response to Hypoxia Mediated by TAK1. Mol Cell Biol 27: 7273-7283.
52. Yasuda J, Whitmarsh AJ, Cavanagh J, Sharma M, Davis RJ (1999) The JIP Group of Mitogen-Activated Protein Kinase Scaffold Proteins. Mol Cell Biol 19: 7245-7254.
53. Whitmarsh AJ, Davis RJ (2001) Analyzing JNK and p38 mitogen-activated protein kinase activity. Methods Enzymol 332: 319-336.
54. Dhanasekaran DN, Johnson GL (2007) MAPKs: function, regulation, role in cancer and therapeutic targeting. Oncogene 26: 3097-3099.
55. Ling Z, Van de Casteele M, Dong J, Heimberg H, Haefliger JA, et al. (2003) Variations in IB1/JIP1 expression regulate susceptibility of beta-cells to cytokine-induced apoptosis irrespective of C-jun NH2-terminal kinase signaling. Diabetes 52: 2497-2502.
56. Eminel S, Klettner A, Roemer L, Herdegen T, Waetzig V (2004) JNK2 translocates to the mitochondria and mediates cytochrome c release in PC12 cells in response to 6-hydroxydopamine. J Biol Chem 279: 55385-55392.
57. Li CH, Wang RM, Zhang QG, Zhang GY (2005) Activated mitogen-activated protein kinase kinase 7 redistributes to the cytosol and binds to Jun N-terminal kinase-interacting protein 1 involving oxidative stress during early reperfusion in rat hippocampal CA1 region. J Neurochem 93: 290-298.
58. Dickens M, Rogers JS, Cavanagh J, Raitano, A, Xia Z, et al. (1997) A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277: 693-696.
59. Kristensen O, Guenat S, Dar I, Allaman-Pillet N, Abderrahmani A, et al. (2006) A unique set of SH3-SH3 interactions controls IB1 homodimerization. Embo J 25: 785-797.
60. Tournier C, Whitmarsh AJ, Cavanagh J, Barrett T, Davis RJ (1999) The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases. Mol Cell Biol 19: 1569-1581.
61. Weston CR, Davis RJ (2002) The JNK signal transduction pathway. Curr Opin Genet Dev 12: 14-21.
62. Willoughby EA, Perkins GR, Collins MK, Whitmarsh AJ (2003) The JNK-interacting protein-1 scaffold protein targets MAPK phosphatase-7 to dephosphorylate JNK. J Biol Chem 278: 10731-10736.
63. Kim AH. Yano H, Cho H, Meyer D, Monks B. et al. (2002) Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron 35: 697-709.
64. Kim AH, Sasaki T, Chao MV (2003) JNK-interacting protein 1 promotes Akt1 activation. J Biol Chem 278: 29830-29836.
65. Kim JW, Kim MJ, Kim KJ, Yun HJ, Chae JS, et al. (2005) Notch interferes with the scaffold function of JNK-interacting protein 1 to inhibit the JNK signaling pathway. Proc Natl Acad Sci U S A 102: 14308-14313.
66. Muzio M. Polentarutti N. Bosisio D. Prahladan MK, Mantovani A (2000) Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes. J Leukoc Biol 67: 450-456.
67. Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3: 745-756.
68. Beutler B, Jiang Z, Georgel P, Crozat K, Croker B, et al. (2006) Genetic analysis of host resistance: Toll-Like Receptor Signaling and Immunity at Large. Annu Rev Immunol 24: 353-389.
69. Kishimoto K, Matsumoto K, Ninomiya-Tsuji J (2000) TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop. J Biol Chem 275: 7359-7364.